Xie C - Search Results

1

Erratum: MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity.

Sun Y, Sun X, You C, Ma S, Luo Y, Peng S, Tang F, Tian X, Wang F, Huang Z, Yu H, Xiao Y, Wang X, Zhang J, Gong Y, Xie C. Sun Y, et al. Among authors: xie c. Int J Biol Sci. 2022 Nov 3;18(16):6226. doi: 10.7150/ijbs.79140. eCollection 2022. Int J Biol Sci. 2022. PMID: 36439877 Free PMC article.

2

Redistribution of DR4 and DR5 in lipid rafts accounts for the sensitivity to TRAIL in NSCLC cells.

Ouyang W, Yang C, Liu Y, Xiong J, Zhang J, Zhong Y, Zhang G, Zhou F, Zhou Y, Xie C. Ouyang W, et al. Among authors: xie c. Int J Oncol. 2011 Dec;39(6):1577-86. doi: 10.3892/ijo.2011.1129. Epub 2011 Jul 18. Int J Oncol. 2011. PMID: 21769428

3

Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells.

Ouyang W, Yang C, Zhang S, Liu Y, Yang B, Zhang J, Zhou F, Zhou Y, Xie C. Ouyang W, et al. Among authors: xie c. Int J Oncol. 2013 Feb;42(2):699-711. doi: 10.3892/ijo.2012.1748. Epub 2012 Dec 20. Int J Oncol. 2013. PMID: 23258590

4

β-catenin is regulated by USP9x and mediates resistance to TRAIL-induced apoptosis in breast cancer.

Ouyang W, Zhang S, Yang B, Yang C, Zhang J, Zhou F, Xie C. Ouyang W, et al. Among authors: xie c. Oncol Rep. 2016 Feb;35(2):717-24. doi: 10.3892/or.2015.4463. Epub 2015 Nov 27. Oncol Rep. 2016. PMID: 26717875

5

HDAC6-mediated EGFR stabilization and activation restrict cell response to sorafenib in non-small cell lung cancer cells.

Wang Z, Hu P, Tang F, Xie C. Wang Z, et al. Among authors: xie c. Med Oncol. 2016 May;33(5):50. doi: 10.1007/s12032-016-0765-5. Epub 2016 Apr 18. Med Oncol. 2016. PMID: 27090797

6

HDAC6 promotes cell proliferation and confers resistance to gefitinib in lung adenocarcinoma.

Wang Z, Tang F, Hu P, Wang Y, Gong J, Sun S, Xie C. Wang Z, et al. Among authors: xie c. Oncol Rep. 2016 Jul;36(1):589-97. doi: 10.3892/or.2016.4811. Epub 2016 May 16. Oncol Rep. 2016. PMID: 27221381

7

HDAC6 promotes cell proliferation and confers resistance to temozolomide in glioblastoma.

Wang Z, Hu P, Tang F, Lian H, Chen X, Zhang Y, He X, Liu W, Xie C. Wang Z, et al. Among authors: xie c. Cancer Lett. 2016 Aug 28;379(1):134-42. doi: 10.1016/j.canlet.2016.06.001. Epub 2016 Jun 3. Cancer Lett. 2016. PMID: 27267806

8

ATG7 promotes the tumorigenesis of lung cancer but might be dispensable for prognosis predication: a clinicopathologic study.

Sun S, Wang Z, Tang F, Hu P, Yang Z, Xue C, Gong J, Shi L, Xie C. Sun S, et al. Among authors: xie c. Onco Targets Ther. 2016 Aug 11;9:4975-81. doi: 10.2147/OTT.S107876. eCollection 2016. Onco Targets Ther. 2016. PMID: 27563251 Free PMC article.

9

The effect of the TLR9 ligand CpG-oligodeoxynucleotide on the protective immune response to radiation-induced lung fibrosis in mice.

Chen J, Tian X, Mei Z, Wang Y, Yao Y, Zhang S, Li X, Wang H, Zhang J, Xie C. Chen J, et al. Among authors: xie c. Mol Immunol. 2016 Dec;80:33-40. doi: 10.1016/j.molimm.2016.11.001. Epub 2016 Nov 5. Mol Immunol. 2016. PMID: 27825048

10

Downregulation of LAPTM5 suppresses cell proliferation and viability inducing cell cycle arrest at G0/G1 phase of bladder cancer cells.

Chen L, Wang G, Luo Y, Wang Y, Xie C, Jiang W, Xiao Y, Qian G, Wang X. Chen L, et al. Among authors: xie c. Int J Oncol. 2017 Jan;50(1):263-271. doi: 10.3892/ijo.2016.3788. Epub 2016 Dec 5. Int J Oncol. 2017. PMID: 27922670

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,374 results

Search Page

Filters